Bruker’s majority‑owned subsidiary RI Research Instruments announced a new order worth approximately €35 million (over $40 million) for key components and subsystems of the gamma‑ray source at the Extreme Light Infrastructure – Nuclear Physics (ELI‑NP) facility in Romania. The contract covers the full inverse Compton scattering system, including an optical resonator that amplifies the laser beam by more than 900× and a linac upgrade that will increase pulse rate by 200×. Delivery is scheduled for late 2026.
The gamma‑ray source will generate a high‑flux, monochromatic beam that will enable researchers to probe nuclear processes that occurred minutes after the Big Bang. The technical specifications—900× laser amplification and 200× pulse‑rate increase—represent a significant leap in performance for the facility and position RI as a key supplier of advanced laser‑accelerator technology.
For Bruker, the deal adds a multi‑million‑dollar contract to its high‑performance instrumentation portfolio and signals a strategic push into high‑end research instrumentation. In FY 2024 Bruker generated $3.37 billion in revenue, and the €35 million contract represents roughly 1 % of that figure. While the contract is modest relative to Bruker’s overall top line, it demonstrates the company’s ability to win large, technically demanding projects that can diversify revenue streams beyond its core scientific instruments.
Bruker’s CFO Gerald Herman said the company is focused on “significant margin expansion and double‑digit EPS growth in fiscal year 26.” The contract aligns with that goal by adding a high‑margin, long‑term project that will generate revenue over several years. However, Bruker’s recent guidance for FY 2025 was revised downward, reflecting concerns about order flow and government funding trends in research markets.
Analysts view the ELI‑NP contract as a positive addition to Bruker’s high‑performance instrumentation segment, but they also note that the company continues to face headwinds such as pricing pressure in legacy markets and cost inflation. The contract’s technical complexity and long‑term delivery schedule suggest that Bruker is investing in high‑return verticals that could help offset broader market challenges.
Overall, the €35 million contract underscores Bruker’s continued expansion into advanced research infrastructure, providing a new revenue stream that complements its existing product lines while reinforcing its position as a leading supplier of high‑performance scientific instrumentation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.